MedTrace Logo

A Postmarket Clinical Follow Up Study (PMCF) to Evaluate the Safety and Performance of VERIFORTE/Granudacyn® Med Wound Irrigation Solution.

NCT06083740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2023-10-16

No results posted yet for this study

Summary

In the course of this clinical trial, it was shown that the use of Granudacyn/VERIFORTE med wound irrigation solution in the course of adjuvant therapy supports wound healing through mechanical irrigation and moistening of the wound. No risks have been reported. The benefits of using Granudacyn/VERIFORTE med wound irrigation solution therefore outweigh the potential risks.

Conditions

  • Wounds

Interventions

DEVICE

Granudacyn/Veriforte

Wound irrigation solution for all kinds of wounds (Acute, chronic or contaminated wounds).

Sponsors & Collaborators

  • WPM - Wund Pflege Management Ges.m.b.H

    collaborator UNKNOWN

  • P.G.F. Industry Solutions GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-03-01
Completion
2023-06-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06083740 on ClinicalTrials.gov